幽门螺杆菌与结直肠肿瘤的相关性研究进展
Progress of Research on Correlation between Helicobacter pylori and Colorectal Neoplasms
DOI: 10.12677/acm.2025.1551559, PDF,   
作者: 杨 群：内蒙古民族大学第二临床医学院，内蒙古 牙克石；曹金恒*：内蒙古林业总医院消化内镜中心，内蒙古 牙克石
关键词: 幽门螺杆菌；结直肠肿瘤；相关性；致病机制；Helicobacter pylori； Colorectal Neoplasms； Correlation； Pathogenic Mechanisms
摘要: 幽门螺杆菌(Helicobacter pylori, Hp)是一种全球性病原体，其致病机制与人类肿瘤发生发展的相关性持续受到学界关注。近年来大量研究证实，Hp感染除与胃癌有明确因果关系外，其与结直肠肿瘤的发病风险存在显著关联，特别是相关机制研究已成为当前消化系统肿瘤领域的热点。本文通过探讨两者之间的概念、流行病学、相关性、致病机制及治疗作一全面综述，期望能够增强大众对这两种疾病的认识，并为其预防与治疗提供有益的参考和见解。
Abstract: Helicobacter pylori (Hp) is a global pathogen, and the correlation between its pathogenic mechanism and the development of human tumors continues to attract academic attention. In recent years, a large number of studies have confirmed that Hp infection has a clear causal relationship with gastric cancer, and it is significantly associated with the risk of colorectal neoplasms, especially the related mechanism research has become a hot spot in the field of digestive system tumors. By discussing the concept, epidemiology, correlation, pathogenesis and treatment of the two diseases, this paper makes a comprehensive review, hoping to enhance the public’s understanding of the two diseases and provide useful reference and insight for their prevention and treatment.
文章引用：杨群, 曹金恒. 幽门螺杆菌与结直肠肿瘤的相关性研究进展[J]. 临床医学进展, 2025, 15(5): 1799-1806. https://doi.org/10.12677/acm.2025.1551559

参考文献

[1] 刘丹凤, 郑奎城. 幽门螺杆菌毒力因子CagA和VacA多样性与胃部疾病关系研究进展[J]. 海峡预防医学杂志, 2018, 24(1): 16-20.
[2] 张旺发, 李明欣, 陈荣鹏, 等. Ⅳ期结直肠癌化疗前血小板参数与化疗敏感性及预后的关系[J]. 实用医学杂志, 2021, 37(20): 2608-2613.
[3] 白金权, 陆雨清, 潘炫豪, 等. 幽门螺杆菌与结直肠癌关系的研究进展[J]. 吉林医药学院学报, 2022, 43(6): 461-463.
[4] 孙振灿, 张晓彤, 王军, 等. 幽门螺杆菌毒力因子及其诱发胃癌作用机制研究进展[J]. 山东医药, 2024, 64(2): 104-107.
[5] Kharel, S., Bist, A., Shrestha, S. and Homagain, S. (2020) Helicobacter pylori Healthy South Asians. JGH Open, 4, 1037-1046. [Google Scholar] [CrossRef] [PubMed]
[6] World Gastroenterology Organisation (2011) World Gastroenterology Organisation Global Guideline: Helicobacter pylori in Developing Countries. Journal of Clinical Gastroenterology, 45, 383-388.
[7] 张万岱, 胡伏莲, 萧树东, 等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗, 2010, 15(5): 265-270.
[8] Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y., Li, Q., et al. (2021) Prevalence of Helicobacter pylori Infection in China: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology, 37, 464-470. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, Y.C., Malfertheiner, P., Yu, H.T., et al. (2024) Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022. Gastroenterology, 166, 605-619. [Google Scholar] [CrossRef] [PubMed]
[10] Xie, L., Liu, G., Liu, Y., Li, P., Hu, X., He, X., et al. (2024) Prevalence of Helicobacter pylori Infection in China from 2014-2023: A Systematic Review and Meta-Analysis. World Journal of Gastroenterology, 30, 4636-4656. [Google Scholar] [CrossRef] [PubMed]
[11] 程婷, 芦永福. 结直肠息肉发生相关因素的研究进展[J]. 现代医药卫生, 2021, 37(19): 3295-3299.
[12] 苑旭晔, 陈宏桢, 郭金波, 等. 《第六次全国幽门螺杆菌感染处理共识报告(非根除治疗部分)》解读[J]. 河北医科大学学报, 2023, 44(3): 249-251.
[13] Smith, S.M., Boyle, B., Buckley, M., Costigan, C., Doyle, M., Farrell, R., et al. (2024) The Second Irish Helicobacter pylori Working Group Consensus for the Diagnosis and Treatment of Helicobacter pylori Infection in Adult Patients in Ireland. European Journal of Gastroenterology & Hepatology, 36, 1000-1009. [Google Scholar] [CrossRef] [PubMed]
[14] Chao, G., Zhu, Y. and Fang, L. (2020) Retrospective Study of Risk Factors for Colorectal Adenomas and Non-Adenomatous Polyps. Translational Cancer Research, 9, 1670-1677. [Google Scholar] [CrossRef] [PubMed]
[15] 李兵, 王士旭, 刘艺行, 等. 结直肠腺瘤发生机制的研究进展[J]. 中国普外基础与临床杂志, 2024, 31(12): 1540-1544.
[16] 张正, 张莉芳, 刘彦廷, 等. 《2022全球癌症统计报告》解读[J]. 中国医院统计, 2024, 31(5): 393-400.
[17] Meucci, G., Tatarella, M., Vecchi, M., Ranzi, M.L., Biguzzi, E., Beccari, G., et al. (1997) High Prevalence of Helicobacter pylori Infection in Patients with Colonic Adenomas and Carcinomas. Journal of Clinical Gastroenterology, 25, 605-607. [Google Scholar] [CrossRef] [PubMed]
[18] Shmuely, H., Passaro, D., Figer, A., Niv, Y., Pitlik, S., Samra, Z., et al. (2001) Relationship between Helicobacter pylori CagA Status and Colorectal Cancer. The American Journal of Gastroenterology, 96, 3406-3410. [Google Scholar] [CrossRef] [PubMed]
[19] Sonnenberg, A. and Genta, R.M. (2013) Helicobacter pylori Is a Risk Factor for Colonic Neoplasms. American Journal of Gastroenterology, 108, 208-215. [Google Scholar] [CrossRef] [PubMed]
[20] Hong, S.N., Lee, S.M., Kim, J.H., Lee, T.Y., Kim, J.H., Choe, W.H., et al. (2012) Helicobacter pylori Infection Increases the Risk of Colorectal Adenomas: Cross-Sectional Study and Meta-Analysis. Digestive Diseases and Sciences, 57, 2184-2194. [Google Scholar] [CrossRef] [PubMed]
[21] Lee, J.Y., Park, H.W., Choi, J.Y., Lee, J., Koo, J.E., Chung, E.J., et al. (2016) Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. Gut and Liver, 10, 902-909. [Google Scholar] [CrossRef] [PubMed]
[22] 陈志涛, 王萍, 孙圣斌, 等. 结直肠腺瘤危险因素及幽门螺杆菌感染与腺瘤特征和血清胃泌素水平的相关性研究[J]. 中国全科医学, 2017, 20(2): 154-158.
[23] Wu, Q., Yang, Z.‐P., Xu, P., Gao, L.‐C. and Fan, D.‐M. (2013) Association between Helicobacter pylori Infection and the Risk of Colorectal Neoplasia: A Systematic Review and Meta‐Analysis. Colorectal Disease, 15, e352-e364. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, F., Sun, M.Y., Shi, S.L. and Lv, Z.S. (2014) Helicobacter pylori Infection and Normal Colorectal Mucosa-Adenomatous Polyp-Adenocarcinoma Sequence: A Meta‐Analysis of 27 Case-Control Studies. Colorectal Disease, 16, 246-252. [Google Scholar] [CrossRef] [PubMed]
[25] 冯雪, 雍鑫, 张欢, 等. 幽门螺杆菌感染与结直肠癌关系的Meta分析研究[J]. 西南国防医药, 2018, 28(12): 1253-1256.
[26] 丁竹韵, 严蕙蕙, 蔡建庭. 幽门螺杆菌感染与结直肠息肉相关性的研究进展[J]. 胃肠病学, 2024, 29(2): 124-128.
[27] 张雪梅, 阮君山, 刘丽娜, 等. 幽门螺杆菌､高胃泌素血症对结直肠癌形成的影响[J]. 西安交通大学学报(医学版), 2012, 33(3): 316-320.
[28] 魏以召, 常玉英. 幽门螺杆菌与结肠息肉及结肠癌的相关性研究进展[J]. 现代医药卫生, 2019, 35(17): 2654-2657.
[29] 彭卓嵛, 蔡林坤, 蓝斯莹, 等. COX-2和Cathepsin-D在结直肠癌组织中的表达及临床意义[J]. 中国肿瘤临床与康复, 2020, 27(2): 152-155.
[30] Hartwich, J., Konturek, S.J., Pierzchalski, P., et al. (2001) Molecular Basis of Colorectal Cancer—Role of Gastrin and Cyclooxygenase-2. Medical Science Monitor, 7, 1171-1181.
[31] Negi, R.R., Rana, S.V., Gupta, V., Gupta, R., Chadha, V.D., Prasad, K.K., et al. (2019) Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients. Asian Pacific Journal of Cancer Prevention, 20, 1675-1681. [Google Scholar] [CrossRef] [PubMed]
[32] Kim, S., Margalit, O., Katoh, H., Wang, D., Wu, H., Xia, D., et al. (2014) CG100649, a Novel COX-2 Inhibitor, Inhibits Colorectal Adenoma and Carcinoma Growth in Mouse Models. Investigational New Drugs, 32, 1105-1112. [Google Scholar] [CrossRef] [PubMed]
[33] 伍治平, 蒋永新, 王熙才. 非甾体类抗炎药对大肠癌的化学预防及机理探讨[J]. 肿瘤研究与临床, 2001, 13(2): 142-143.
[34] Zhang, B., Zhang, X., Jin, M., Hu, L., Zang, M., Qiu, W., et al. (2018) CagA Increases DNA Methylation and Decreases PTEN Expression in Human Gastric Cancer. Molecular Medicine Reports, 19, 309-319. [Google Scholar] [CrossRef] [PubMed]
[35] 刘治智, 黄美君, 杨颖强, 等. 结直肠腺瘤细胞毒素相关基因A阳性幽门螺杆菌感染危险因素[J]. 中华医院感染学杂志, 2020, 30(5): 658-662.
[36] Zhang, H., Liao, Y., Zhang, H., Wu, J., Zheng, D. and Chen, Z. (2020) Cytotoxin-Associated Gene a Increases Carcinogenicity of Helicobacter pylori in Colorectal Adenoma. The International Journal of Biological Markers, 35, 19-25. [Google Scholar] [CrossRef] [PubMed]
[37] 王群, 安桂凤. 幽门螺杆菌感染与结直肠息肉的相关性研究进展[J]. 赤峰学院学报(自然科学版), 2024, 40(4): 25-32.
[38] Yang, W. and Yang, X. (2019) Association between Helicobacter pylori Infection and Colorectal Adenomatous Polyps. Gastroenterology Research and Practice, 2019, Article ID: 7480620. [Google Scholar] [CrossRef] [PubMed]
[39] 冯娟, 王晶, 陈安. 结直肠腺瘤合并Hp阳性者血清GAS､炎症因子和肠道菌群分析[J]. 海南医学, 2022, 33(23): 3053-3055.
[40] 金怀亮. 幽门螺杆菌感染对结直肠癌患者化疗敏感性的影响[J]. 肿瘤基础与临床, 2020, 33(3): 214-217.
[41] Zhao, X., Liu, M., Wang, R. and Tian, T. (2020) Effect of Gender and Age on the Correlation between Helicobacter pylori and Colorectal Adenomatous Polyps in a Chinese Urban Population: A Single Center Study. Gastroenterology Research and Practice, 2020, Article ID: 8596038. [Google Scholar] [CrossRef] [PubMed]
[42] Nakajima, T., Enomoto, S. and Ushijima, T. (2007) DNA Methylation: A Marker for Carcinogen Exposure and Cancer Risk. Environmental Health and Preventive Medicine, 13, 8-15. [Google Scholar] [CrossRef] [PubMed]
[43] 张怡, 高梦佳. 结直肠腺瘤合并Hp感染患者的临床特征､肠道菌群分布及血清G-17､PGII表达水平的变化[J]. 海南医学, 2022, 33(24): 3174-3177.
[44] Husebye, E. (2005) The Pathogenesis of Gastrointestinal Bacterial Overgrowth. Chemotherapy, 51, 1-22. [Google Scholar] [CrossRef] [PubMed]
[45] Bernstein, H. and Bernstein, C. (2022) Bile Acids as Carcinogens in the Colon and at Other Sites in the Gastrointestinal System. Experimental Biology and Medicine, 248, 79-89. [Google Scholar] [CrossRef] [PubMed]
[46] 董红霞. 幽门螺杆菌感染对肠道菌群的影响以及与结直肠癌的相关性[D]: [硕士学位论文]. 北京: 中国人民解放军医学院, 2015.
[47] 韩强, 程艳丽. 幽门螺杆菌感染根除治疗研究新进展[J]. 中国研究型医院, 2023, 10(3): 51-55.
[48] 邓婧, 郑明琳, 郭毅, 等. 铋剂四联疗法在幽门螺杆菌根除治疗中的应用现状及研究进展[J]. 实用药物与临床, 2025, 28(1): 74-80.
[49] Hu, K.C., Wu, M.S., Chu, C.H., et al. (2019) Decreased Colorectal Adenoma Risk After Helicobacter pylori Eradication: A Retrospective Cohort Study. Clinical Infectious Diseases, 68, 2105-2113. [Google Scholar] [CrossRef] [PubMed]
[50] Shah, S.C., Camargo, M.C., Lamm, M., Bustamante, R., Roumie, C.L., Wilson, O., et al. (2024) Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort. Journal of Clinical Oncology, 42, 1881-1889. [Google Scholar] [CrossRef] [PubMed]

为你推荐